Koyfin Home > Directory > Health Care > Aeglea Biothera > EV / EBITDA (ntm)

Aeglea Biothera EV / EBITDA (ntm) Chart (AGLE)

Aeglea Biothera annual/quarterly EV / EBITDA (ntm) from 2016 to 2017. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Aeglea Biothera EV / EBITDA (ntm) for the quarter ending August 08, 2017 was 0.07 a -457.72% decrease of -0.32 year over year
  • Aeglea Biothera EV / EBITDA (ntm) for the last 12 months ending August 08, 2017 was 0.07 a -457.72% decrease of -0.32 year over year
  • Aeglea Biothera Annual EV / EBITDA (ntm) for 2017 was 0.07 a -315.13% decrease of -0.22 from 2016
  • Aeglea Biothera Annual EV / EBITDA (ntm) for 2017 was 0.29 a -3.62% decrease of -0.01 from 2016
  • Aeglea Biothera Annual EV / EBITDA (ntm) for 2017 was 0.30 a -29.66% decrease of -0.09 from 2016
Other Valuation Metrics:
  • Aeglea Biothera Market Cap for the quarter ending March 03, 2018 was $166m a 61.80% increase of 102m year over year
  • Aeglea Biothera Price / Book for the quarter ending March 03, 2018 was 3.29 a 72.43% increase of 2.38 year over year
  • Aeglea Biothera Enterprise Value for the quarter ending March 03, 2018 was $116m a 95.26% increase of 110m year over year
View Chart On Koyfin

Quarterly AGLE EV / EBITDA (ntm) Data

08/20170.07
08/20170.29
08/20170.30
08/20170.39
08/20170.41
08/20170.39
08/20170.44
08/20170.46
08/20170.49
08/20170.47

Annual AGLE EV / EBITDA (ntm) Data

20170.07
20170.29
20170.30
20170.39
20170.41
20170.39
20170.44
20170.46
20170.49
20170.47